CHINA SHINEWAY PHARMACEUTICAL GR financial statements, including revenue, expenses, profit, and loss

The total revenue of 2877 for the last semiannual is 2.26 B HKD, and it's 1.17% lower compared to the previous semiannual. The net income of H1 24 is 678.87 M HKD.